|
2024
|
Invention
|
Capsule formulations.
The present disclosure provides solid solution capsule formulations of Com... |
|
|
Invention
|
Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor.
T... |
|
2023
|
Invention
|
Compositions and methods for treating inflammatory bowel disease using ccr9 inhibitor and anti-il... |
|
|
Invention
|
Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases.
Compounds are provided that are ... |
|
|
Invention
|
Methods of treating cancer using heteroaryl-biphenyl amide derivatives.
Provided herein are meth... |
|
|
Invention
|
Heteroaryl-biphenyl amides for the treatment of pd-l1 diseases.
Compounds are provided that are ... |
|
|
Invention
|
Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1 and/or pd-l1 inhibi... |
|
|
Invention
|
Free base crystalline form of a complement component c5a receptor.
Provided herein is a free bas... |
|
|
Invention
|
Ccr4 antagonists.
Compounds are provided having formula (I):
Compounds are provided having for... |
|
|
Invention
|
Ccr4 antagonists. Compounds are provided having formula (I) wherein the groups/letters R1a, R1b, ... |
|
|
Invention
|
Cxcr6 sulfonamide compounds.
Provided are sulfonamide compounds having formula (I):
Provided a... |
|
|
Invention
|
Cxcr6 sulfonamide compounds. Provided are sulfonamide compounds having formula (I) or a pharmaceu... |
|
2022
|
Invention
|
C5ar antagonists.
Compounds are provided that are modulators of the C5a receptor. The compounds ... |
|
|
Invention
|
Diaryl substituted 6,5-fused ring compounds as c5ar inhibitors.
The present disclosure provides,... |
|
|
Invention
|
Aryl sulfonyl compounds as ccr6 inhibitors. Compounds of formula (I) are provided which are usefu... |
|
|
Invention
|
Aryl sulfonyl (hydroxy) piperidines as ccr6 inhibitors. Compounds of formula (A) are provided whi... |
|
|
Invention
|
Combination therapy using c—c chemokine receptor 4 (ccr4) antagonists and one or more immune chec... |
|
|
Invention
|
2-oxindole compounds. Oxindole compounds useful for the treatment of CCR(9) mediated conditions o... |
|
|
Invention
|
C5ar inhibitor reduction of urinary scd163.
Provided herein are methods of treating ANCA-associa... |
|
|
Invention
|
Cxcr7 inhibitors for the treatment of cancer.
Provided herein are methods of treating cancer in ... |
|
|
Invention
|
Immunomodulator compounds. Compounds are provided that are useful as immunomodulators. The compou... |
|
|
Invention
|
Treatment of focal segmental glomerulosclerosis with ccr2 antagonists.
Provided herein are metho... |
|
|
P/S
|
Pharmaceutical products for the treatment of autoimmune and inflammatory diseases |
|
|
Invention
|
Method of treating liver fibrosis.
A method of treating liver fibrosis with CCR2 antagonists is ... |
|
|
Invention
|
6-5 fused rings as c5a inhibitors. The present disclosure provides, inter alia, Compounds of Form... |
|
|
Invention
|
Azetidinyl-acetamides as cxcr7 inhibitors.
Compounds having formula I,
Compounds having formul... |
|
|
Invention
|
Azetidinyl-acetamides as cxcr7 inhibitors. Compounds having formula I: (I), or pharmaceutically a... |
|
|
Invention
|
Method of treating focal segmental glomerulosclerosis.
A method of treating focal segmental glom... |
|
|
Invention
|
Method of treating c3 glomerulopathy. aR antagonist are provided. |
|
|
Invention
|
Processes and intermediates in the preparation of c5ar antagonists. Intermediates and methods are... |
|
|
Invention
|
Triaryl compounds for treatment of pd-l1 diseases.
Compounds are provided that are useful as imm... |
|
2021
|
Invention
|
Treatment of c3 glomerulopathy using a c5a inhibitor.
Methods of treating certain human patient ... |
|
|
Invention
|
Treatment of c3 glomerulopathy using a c5a inhibitor. Methods of treating certain human patient p... |
|
|
Invention
|
Capsule formulations. The present disclosure provides solid solution capsule formulations of Comp... |
|
|
Invention
|
Methods of treating generalized pustular psoriasis with an antagonist of ccr6 or cxcr2. The prese... |
|
|
Invention
|
Dosing and effect of c5a antagonist with anca-associated vasculitis.
The present disclosure prov... |
|
|
Invention
|
Methods of treating hidradenitis suppurativa. Provided herein are methods for treating a subject ... |
|
|
Invention
|
Methods of treating solid tumors with ccr2 antagonists.
The present disclosure provides, inter a... |
|
|
Invention
|
Substituted anilines as ccr(4) antagonists. Aniline compounds are provided which bind to CCR(4) a... |
|
|
Invention
|
Indane-amines as pd-l1 antagonists. Compounds are provided that are useful as immunomodulators. T... |
|
|
Invention
|
Substituted tetrahydropyrans as ccr2 modulators. Compounds are provided that are modulators of th... |
|
|
Invention
|
Cxcr7 antagonists. Compounds having formula I,
or pharmaceutically acceptable salts, hydrates o... |
|
2020
|
P/S
|
Pharmaceutical preparations for use in the treatment of human disease, namely, inflammatory and a... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of human disease, namely, inflammatory bowel... |
|
2018
|
P/S
|
Pharmaceutical products. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases; anti-inflammatories, anti-i... |
|
2009
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
P/S
|
Full line of pharmaceutical preparations. |
|
|
P/S
|
PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF HUMAN DISEASE, NAMELY, INFLAMMATORY AND A... |
|
2006
|
P/S
|
Pharmaceutical preparations for use in the treatment of
human disease, namely, inflammatory and ... |
|
|
P/S
|
RESEARCH AND DEVELOPMENT FOR NEW PRODUCTS IN THE FIELD OF CHEMOKINES AND GENETIC MATERIALS FOR OT... |
|
2004
|
P/S
|
Cooperative advertising and marketing for pharmaceuticals
and therapeutics; retail services feat... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of human disease, including inflammatory and... |
|
2002
|
P/S
|
Cooperative advertising and marketing for pharmaceuticals and therapeutics; retail and wholesale ... |
